相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up
Cristina Barale et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study
Francesco Finamore et al.
JOURNAL OF PROTEOMICS (2019)
GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
Maria N. Barrachina et al.
ATHEROSCLEROSIS (2019)
Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
Asmaa M. Zahran et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Analysis of Post-Sample Collection EDTA Effects on Mean Platelet Volume Values in Relation to Overweight and Obese Patient Status
Renata V. L. Pinto et al.
ACTA HAEMATOLOGICA (2019)
Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin
Cristina Barale et al.
THROMBOSIS RESEARCH (2019)
Platelet-derived chemokines in inflammation and atherosclerosis
Constantinos Bakogiannis et al.
CYTOKINE (2019)
Alterations to to the contents of plasma membrane structural lipids are associated with structural changes and compartmentalization in platelets in hypertension
Diana Garcia-Rubio et al.
EXPERIMENTAL CELL RESEARCH (2019)
Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells
Rosalia Grande et al.
FRONTIERS IN PHARMACOLOGY (2019)
Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients
Adel Abdel-Moneim et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Impaired platelet activation in patients with hereditary deficiency of p47(phox)
Roberto Carnevale et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications
Melania Dovizio et al.
CANCER AND METASTASIS REVIEWS (2018)
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis
Milka Koupenova et al.
CIRCULATION RESEARCH (2018)
Regulation of von-Willebrand Factor Secretion from Endothelial Cells by the Annexin A2-S100A10 Complex
Anna Holthenrich et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Simvastatin Modulates Interaction Between Vascular Smooth Muscle Cell/Macrophage and TNF-α-Activated Endothelial Cell
Fujiang Chu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
PCSK9 as a Positive Modulator of Platelet Activation
Marina Camera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The CD40/CD40L system regulates rat cerebral microvasculature after focal ischemia/reperfusion via the mTOR/S6K signaling pathway
Run-Hao Jiang et al.
NEUROLOGICAL RESEARCH (2018)
Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
Isabella Russo et al.
FRONTIERS IN PHYSIOLOGY (2018)
E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy
Mariana Silva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Significance of urinary 11-dehydro-thromboxane B-2 in age-related diseases: Focus on atherothrombosis
Paola Simeone et al.
AGEING RESEARCH REVIEWS (2018)
Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
Paola Simeone et al.
NUTRIENTS (2018)
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
Cristina Barale et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The Impact of Obesity on the Cardiovascular System
Imre Csige et al.
JOURNAL OF DIABETES RESEARCH (2018)
Effect of Bariatric Surgery-Induced Weight Loss on Platelet Count and Mean Platelet Volume: a 12-Month Follow-Up Study
Loic Raoux et al.
OBESITY SURGERY (2017)
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
Eliano P. Nayarese et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin
Jitendra S. Kanshana et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation
Daniele Pastori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Ashkan Afshin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
Gijs H. Goossens
OBESITY FACTS (2017)
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
Cristina Barale et al.
THROMBOSIS AND HAEMOSTASIS (2017)
The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature
Evangelos Diamantis et al.
CURRENT CARDIOLOGY REVIEWS (2017)
Platelets, diabetes and myocardial ischemia/reperfusion injury
Isabella Russo et al.
CARDIOVASCULAR DIABETOLOGY (2017)
New insights into the role of adipose tissue in thrombosis
Gemma Vilahur et al.
CARDIOVASCULAR RESEARCH (2017)
Thrombosis in diabetes: a shear flow effect?
Erik Westein et al.
CLINICAL SCIENCE (2017)
Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
Alison Cameron-Vendrig et al.
DIABETES (2016)
Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation
S. I. Obydennyy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Microparticles as new markers of cardiovascular risk in diabetes and beyond
Francesca Santilli et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome
Madhukar S. Patel et al.
Translational Research (2016)
P-selectin and subclinical and clinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
Suzette J. Bielinski et al.
ATHEROSCLEROSIS (2015)
Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices
Qi Da et al.
BLOOD (2015)
Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade
Simbarashe Magwenzi et al.
BLOOD (2015)
Biologicals, platelet apoptosis and human diseases: An outlook
R. M. Thushara et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
The role of metabolic syndrome in heart failure
Pasquale Perrone-Filardi et al.
EUROPEAN HEART JOURNAL (2015)
The Relationship between the Plasma PCSK9 Levels and Platelet Indices in Patients with Stable Coronary Artery Disease
Sha Li et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Platelet secretory behaviour: as diverse as the granules ... or not?
H. Heijnen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies
Barbara Sottero et al.
MEDICINAL RESEARCH REVIEWS (2015)
Platelets and diabetes mellitus
Francesca Santilli et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Obesity and Antiplatelets-Does One Size Fit All?
Craig J. Beavers et al.
THROMBOSIS RESEARCH (2015)
A novel truncated form of eNOS associates with altered vascular function
Elena Galluccio et al.
CARDIOVASCULAR RESEARCH (2014)
Aldose Reductase-Mediated Phosphorylation of p53 Leads to Mitochondrial Dysfunction and Damage in Diabetic Platelets
Wai Ho Tang et al.
CIRCULATION (2014)
Epithelial sodium channel modulates platelet collagen activation
Doris Cerecedo et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Adipocyte dysfunction, inflammation and metabolic syndrome
Nora Kloeting et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Neutrophils scan for activated platelets to initiate inflammation
Vinatha Sreeramkumar et al.
SCIENCE (2014)
Antiplatelet Therapy: Targeting the TxA2 Pathway
P. Fontana et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2014)
A Short-Term Incubation with High Glucose Impairs VASP Phosphorylation at Serine 239 in response to the Nitric Oxide/cGMP Pathway in Vascular Smooth Muscle Cells: Role of Oxidative Stress
Isabella Russo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Adipose tissue and vascular inflammation in coronary artery disease
Enrica Golia et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
A novel flow cytometry-based platelet aggregation assay
Iris M. De Cuyper et al.
BLOOD (2013)
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Nabil G. Seidah
CURRENT PHARMACEUTICAL DESIGN (2013)
Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
M. Cattaneo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
PATHOPHYSIOLOGY OF HUMAN VISCERAL OBESITY: AN UPDATE
Andre Tchernof et al.
PHYSIOLOGICAL REVIEWS (2013)
State of the Art in Platelet Function Testing
Beate E. Kehrel et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2013)
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Kyung Ho Kim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Insulin resistance is not necessarily an essential element of metabolic syndrome
Rudruidee Karnchanasorn et al.
ENDOCRINE (2013)
High-Sensitivity Flow Cytometry Provides Access to Standardized Measurement of Small-Size Microparticles-Brief Report
Stephane Robert et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study
S. Novo et al.
ATHEROSCLEROSIS (2012)
The Cardiovascular Effects of GLP-1 Receptor Agonists
Theodore Okerson et al.
CARDIOVASCULAR THERAPEUTICS (2012)
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
Isabella Russo et al.
DIABETES (2012)
Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
Roberto Cangemi et al.
DIABETES (2012)
Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes
Anja J. Gerrits et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Platelet activation in obesity and metabolic syndrome
F. Santilli et al.
OBESITY REVIEWS (2012)
The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance
Isabella Russo
SCIENTIFICA (2012)
Thromboxane Production in Morbidly Obese Subjects
Francesca Graziani et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
Karin Przyklenk et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
CD40L Deficiency Ameliorates Adipose Tissue Inflammation and Metabolic Manifestations of Obesity in Mice
Marjorie Poggi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction
Pasquale Pignatelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Guidelines for the laboratory investigation of heritable disorders of platelet function
Paul Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane
Wai Ho Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Dampening insulin signaling by an NLRP3 'meta-flammasome'
Augustine M. K. Choi et al.
NATURE IMMUNOLOGY (2011)
Linking the inflammasome to obesity-related disease
Tiffany Horng et al.
NATURE MEDICINE (2011)
Currently available methods for platelet function analysis: advantages and disadvantages
Rajbabu Pakala et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2011)
Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry
Catherine P. M. Hayward et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Cysteine sulfenic Acid as an Intermediate in Disulfide Bond Formation and Nonenzymatic Protein Folding
Douglas S. Rehder et al.
BIOCHEMISTRY (2010)
Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia
Yi Ma et al.
BLOOD (2010)
CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Hyung Jun Jeon et al.
CIRCULATION (2010)
Thromboxane and the thromboxane receptor in cardiovascular disease
Emer M. Smyth
CLINICAL LIPIDOLOGY (2010)
Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus
Cezary Watala et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling
Hsiu-Chung Ou et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Metabolic Syndrome and Risk of Acute Myocardial Infarction A Case-Control Study of 26,903 Subjects From 52 Countries
Andrew Mente et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
Giovanni Anfossi et al.
MEDIATORS OF INFLAMMATION (2010)
Chronic Inflammation in Obesity and the Metabolic Syndrome
Rosario Monteiro et al.
MEDIATORS OF INFLAMMATION (2010)
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin
Isabella Russo et al.
OBESITY (2010)
The Contribution of the Framingham Heart Study to the Prevention of Cardiovascular Disease: A Global Perspective
Shanthi Mendis
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease
Benjamin Sadowitz et al.
VASCULAR AND ENDOVASCULAR SURGERY (2010)
Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients
Shosaku Nomura et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
Anna C. Calkin et al.
CIRCULATION (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Platelet receptors and signaling in the dynamics of thrombus formation
Jose Rivera et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells
Subrata Chakrabarti et al.
IMMUNOLOGY LETTERS (2009)
Platelet dysfunction in central obesity
G. Anfossi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Contribution of insulin resistance to vascular dysfunction
Giovanni Anfossi et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Metabolic syndrome pandemic
Scott M. Grundy
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients
Patrizia Ferroni et al.
CLINICA CHIMICA ACTA (2008)
Investigating the mechanisms of hyporesponse to antiplatelet approaches
Eugene Braunwald et al.
CLINICAL CARDIOLOGY (2008)
Metabolic Syndrome and Stroke
Amytis Towfighi et al.
CURRENT DIABETES REPORTS (2008)
Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages
Ernesto Oviedo-Orta et al.
IMMUNOLOGY (2008)
From low-density lipoprotein to platelet activation
Jan Willem N. Akkerman
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
sP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors
G. De Pergola et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Mean platelet volume not so far from being a routine diagnostic and prognostic measurement
Ertan Yetkin
THROMBOSIS AND HAEMOSTASIS (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor
Hiuwan Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity
Heather K. Vincent et al.
DIABETES OBESITY & METABOLISM (2007)
Insulin action and insulin resistance in vascular endothelium
Ranganath Muniyappa et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2007)
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein
Isabella Russo et al.
CLINICAL CHEMISTRY (2007)
The link between abdominal obesity, metabolic syndrome and cardiovascular disease
S. A. Ritchie et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: Implication in obesity-associated cardiovascular diseases
Hisham S. Elbatarny et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Impact of cardiometabolic risk factor clusters on health-related quality of life in the US
Patrick W. Sullivan et al.
OBESITY (2007)
The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes - Mediation by superoxide production, resolution with intensive insulin administration
Matthew I. Worthley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity
Takashi Murakami et al.
THROMBOSIS RESEARCH (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Endothelial and antithrombotic actions of HDL
Chieko Mineo et al.
CIRCULATION RESEARCH (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus
F Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Adiponectin acts as an endogenous antithrombotic factor
H Kato et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Giovanni Anfossi et al.
CURRENT DIABETES REVIEWS (2006)
Platelet nitric oxide responsiveness - A novel prognostic marker in acute coronary syndromes
SR Willoughby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity
MR Barnard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets
PC Williams et al.
BLOOD (2005)
The mean platelet volume in patients with obesity
E Coban et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension
WC Tsai et al.
CLINICAL SCIENCE (2005)
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
ES Ford
DIABETES CARE (2005)
Soluble CD40 ligand in acute and chronic heart failure
T Ueland et al.
EUROPEAN HEART JOURNAL (2005)
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus:: effect of improved metabolic control
F Cipollone et al.
DIABETOLOGIA (2005)
Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation
P Dandona et al.
CIRCULATION (2005)
P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes
H Matsuno et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Global burden of hypertension: analysis of worldwide data
PM Kearney et al.
LANCET (2005)
Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents
M Yamazaki et al.
THROMBOSIS RESEARCH (2005)
Blood platelet reactivity and its pharmacological modulation in (People with) diabetes mellitus
C Watala
CURRENT PHARMACEUTICAL DESIGN (2005)
Increasing prevalance of the metabolic syndrome among U.S adults
ES Ford et al.
DIABETES CARE (2004)
CD40 ligand: A novel target in the fight against cardiovascular disease
D Vishnevetsky et al.
ANNALS OF PHARMACOTHERAPY (2004)
Characteristics of US adults with the metabolic syndrome and therapeutic implications
TA Jacobson et al.
DIABETES OBESITY & METABOLISM (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels
R Riba et al.
ATHEROSCLEROSIS (2004)
Soluble CD40 ligand is an early initiator of inflammation after coronary intervention
A Aggarwal et al.
CORONARY ARTERY DISEASE (2004)
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity
G Anfossi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation
PD Martins et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Contribution of polyol pathway to diabetes-induced oxidative stress
SSM Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease
GM Reaven
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Low-density lipoprotein and its effect on human blood platelets
IAM Relou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Role of P-selectin, β2-integrins, and Src tyrosine kinases in mouse neutrophil-platelet adhesion
V Evangelista et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus
P Gresele et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Comparison between the effects of the rapid recombinant insulin analog lispro (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation
I Russo et al.
THROMBOSIS RESEARCH (2003)
Effects of statins on inflammation in patients with acute and chronic coronary syndromes
S Kinlay et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Signaling through NO and cGMP-dependent protein kinases
J Schlossmann et al.
ANNALS OF MEDICINE (2003)
Mechanisms of endothelial dysfunction: Clinical significance and preventive non-pharmacological therapeutic strategies
S Taddei et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
HM Lakka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Platelets in atherothrombosis
ZM Ruggeri
NATURE MEDICINE (2002)
Platelet activation in obese women -: Role of inflammation and oxidant stress
G Davì et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation
I Russo et al.
THROMBOSIS RESEARCH (2002)
Obesity accelerates the progression of coronary atherosclerosis in young men
HC McGill et al.
CIRCULATION (2002)
Generation of reactive oxygen species in blood platelets
B Wachowicz et al.
PLATELETS (2002)
Effect of leptin on arterial thrombosis following vascular injury in mice
PF Bodary et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
ES Ford et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Inhibition of platelet-collagen interaction - An in vivo action of insulin abolished by insulin resistance in obesity
J Westerbacka et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Insulin resistance and vascular function
AD Baron
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2002)
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Platelet dysfunction in type 2 diabetes
AI Vinik et al.
DIABETES CARE (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of Fluvastatin or Fenofibrate
AD Blann et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart
N Paolocci et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients
A Camilletti et al.
AMERICAN JOURNAL OF HYPERTENSION (2001)
Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension
FM Belgore et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Pro-coagulant state resulting from high levels of soluble P-selecain in blood
P André et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level
TS Temelkova-Kurktschiev et al.
DIABETES CARE (2000)
Cardiovascular responses to the isoprostanes iPF2α-III and iPE2-III are mediated via the thromboxane A2 receptor in vivo
LP Audoly et al.
CIRCULATION (2000)
The role of platelets in diabetes-related vascular complications
AB Sobol et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2000)
分享论文
